These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11011010)

  • 21. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output.
    Huang KX; Walters JR
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual effects of intermittent or continuous L-DOPA administration on gene expression in the globus pallidus and subthalamic nucleus of adult rats with a unilateral 6-OHDA lesion.
    Nielsen KM; Soghomonian JJ
    Synapse; 2003 Sep; 49(4):246-60. PubMed ID: 12827644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of N-methyl-D-aspartate receptors potentiates dopaminergic responses in the 6-OHDA model of Parkinson: differential role of D-1 and D-2 receptors.
    Morelli M; Fenu S; Di Chiara G
    Neurochem Int; 1992 Mar; 20 Suppl():261S-264S. PubMed ID: 1365438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of MK 801 on priming of D1-dependent contralateral turning and its relationship to c-fos expression in the rat caudate-putamen.
    Morelli M; Fenu S; Carta A; Di Chiara G
    Behav Brain Res; 1996 Sep; 79(1-2):93-100. PubMed ID: 8883820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. L-DOPA-induced dyskinesia in adult rats with a unilateral 6-OHDA lesion of dopamine neurons is paralleled by increased c-fos gene expression in the subthalamic nucleus.
    Soghomonian JJ
    Eur J Neurosci; 2006 May; 23(9):2395-403. PubMed ID: 16706847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Augmented sensitivity of D1-dopamine receptors in lateral but not medial striatum after 6-hydroxydopamine-induced lesions in the neonatal rat.
    Simson PE; Johnson KB; Jurevics HA; Criswell HE; Napier TC; Duncan GE; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1454-63. PubMed ID: 1361576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nigrostriatal dopaminergic denervation enhances dopamine D(4) receptor binding in rat caudate-putamen.
    Zhang K; Tarazi FI; Baldessarini RJ
    Pharmacol Biochem Behav; 2001; 69(1-2):111-6. PubMed ID: 11420075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of the acoustic startle response in rats by the dopamine D1 receptor agonist SKF 82958.
    Meloni EG; Davis M
    Psychopharmacology (Berl); 1999 Jun; 144(4):373-80. PubMed ID: 10435410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of dopamine D1-mediated turning behavior and striatal c-fos expression by the substantia nigra.
    Fenu S; Carta A; Morelli M
    Synapse; 1995 Apr; 19(4):233-40. PubMed ID: 7792718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT
    Pinna A; Costa G; Serra M; Contu L; Morelli M
    Neuropharmacology; 2021 Sep; 196():108693. PubMed ID: 34229013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of repeated methyl levodopa administration on apomorphine sensitivity of rotational behavior and striatal Fos expression of rats with unilateral 6-OHDA lesions.
    Kashihara K; Manabe Y; Shiro Y; Warita H; Abe K
    Neurosci Res; 2000 Nov; 38(3):273-9. PubMed ID: 11070194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX; Bergstrom DA; Ruskin DN; Walters JR
    Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test.
    Olsson M; Nikkhah G; Bentlage C; Björklund A
    J Neurosci; 1995 May; 15(5 Pt 2):3863-75. PubMed ID: 7751951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of chronic, systemic treatment with the dopamine receptor agonist R-apomorphine in partially lesioned rat model of Parkinson's disease: an electrophysiological study of substantia nigra dopamine neurons.
    Gui ZH; Liu J; Wang Y; Ali U; Wang T; Chen L
    Chin J Physiol; 2011 Apr; 54(2):96-104. PubMed ID: 21789890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of single and multiple treatments with L-dihydroxyphenylalanine (L-DOPA) on dopamine receptor-G protein interactions and supersensitive immediate early gene responses in striata of rats after reserpine treatment or with unilateral nigrostriatal lesions.
    Khan SM; Smith TS; Bennett JP
    J Neurosci Res; 1999 Jan; 55(1):71-9. PubMed ID: 9890435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of dopamine cell firing by repeated L-DOPA administration to dopamine-depleted rats: its potential role in mediating the therapeutic response to L-DOPA treatment.
    Harden DG; Grace AA
    J Neurosci; 1995 Sep; 15(9):6157-66. PubMed ID: 7666198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway.
    Yoshimura N; Kuno S; Chancellor MB; De Groat WC; Seki S
    Br J Pharmacol; 2003 Aug; 139(8):1425-32. PubMed ID: 12922929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. c-Fos Expression after Stochastic Vestibular Stimulation and Levodopa in 6-OHDA Hemilesioned Rats.
    Samoudi G; Nilsson A; Carlsson T; Bergquist F
    Neuroscience; 2020 Jan; 424():146-154. PubMed ID: 31704349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA.
    Lorenc-Koci E; Czarnecka A; Lenda T; Kamińska K; Konieczny J
    Neurochem Int; 2013 Dec; 63(8):790-804. PubMed ID: 24090640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.